ABSTRACT
BACKGROUND: Prenatal vitamin D deficiency is associated with asthma or recurrent wheezing in offspring. However, evidence from randomized trials on the efficacy of vitamin D supplementation is inconclusive. OBJECTIVES: We aimed to examine the differential efficacy of prenatal vitamin D supplementation based on the maternal baseline vitamin D status and the starting time of supplementation to prevent early life asthma or recurrent wheezing. METHODS: We conducted a secondary analysis of the Vitamin D Antenatal Asthma Reduction Trial (VDAART), a randomized double-blind trial of prenatal vitamin D supplementation initiated at 10-18 weeks (wks) of gestation (4400 IU of intervention/day compared with 400 IU of placebo/day) to prevent offspring asthma or recurrent wheezing by the age of 6 years. We assessed the effect of modification of supplementation by maternal baseline vitamin D status at enrollment and the timing of initiation of supplementation. RESULTS: An inverse relationship was observed between maternal 25-hydroxyvitamin D (25(OH)D) levels at trial entry and 25(OH)D levels during late pregnancy (32-38 wks of gestation) in both supplementation arms (P < 0.001). Overall, supplementation efficacy was not dependent on the maternal baseline 25(OH)D status. However, a trend toward the reduction of asthma or recurrent wheezing was observed across the baseline groups in the intervention arm (P = 0.01), with the greatest reduction observed in the most severely vitamin D-deficient women (25(OH)D < 12 ng/mL; adjusted odds ratio [aOR] = 0.48; confidence interval [CI]: 0.17, 1.34). Gestational age at trial enrollment modified supplementation efficacy, showing a greater reduction of offspring asthma or recurrent wheezing with earlier intervention during pregnancy (aOR = 0.85; CI = 0.76, 0.95), particularly in women who were 9-12 wk pregnant (aOR = 0.45; CI = 0.24, 0.82). CONCLUSIONS: Pregnant women with severe vitamin D deficiency show the greatest 25(OH)D improvement because of supplementation. In these women, a vitamin D dose of 4400 IU might have a preventive role in the development of early life offspring asthma or recurrent wheezing. Gestational age is suggested to modify the efficacy of prenatal vitamin D supplementation, showing the highest beneficial effect if supplementation is started during the first trimester of pregnancy. This study is an ancillary analysis from the VDAART, which is registered in ClinicalTrials.gov as NCT00902621.
Subject(s)
Asthma , Vitamin D Deficiency , Female , Pregnancy , Humans , Child , Respiratory Sounds/etiology , Gestational Age , Dietary Supplements , Vitamin D , Vitamins/pharmacology , Vitamins/therapeutic use , Calcifediol , Asthma/prevention & control , Asthma/etiology , Vitamin D Deficiency/complications , Vitamin D Deficiency/prevention & controlABSTRACT
Longitudinal studies have demonstrated that altered indices of airway function, assessed shortly after birth, are a risk factor for the subsequent development of wheezing illnesses and asthma, and that these indices predict airway size and airway wall thickness in adult life. Pre- and postnatal factors that directly alter early airway function, such as extreme prematurity and cigarette smoke, may continue to affect airway function and, hence, the risks for wheeze and asthma. Early airway function and an associated asthma risk may also be indirectly influenced by immune system responses, respiratory viruses, the airway microbiome, genetics, and epigenetics, especially if they affect airway epithelial dysfunction. Few if any interventions, apart from smoking avoidance, have been proven to alter the risks of developing asthma, but vitamin C supplementation to pregnant smokers may help decrease the effects of in utero smoke on offspring lung function. We conclude that airway size and the factors influencing this play an important role in determining the risk for asthma across the lifetime. Progress in asthma prevention is long overdue and this may benefit from carefully designed interventions in well-phenotyped longitudinal birth cohorts with early airway function assessments monitored through to adulthood.
Subject(s)
Asthma , Pregnancy , Female , Adult , Child , Humans , Asthma/complications , Risk Factors , Respiratory Sounds/etiology , Longitudinal Studies , LungABSTRACT
Maternal intake of folic acid supplements is reportedly associated with the risk of early-onset allergies in offspring. However, only a few studies have considered the intake of both folic acid supplements and dietary folate. Here, the relationship between maternal intake of folic acid supplements and allergic symptoms such as wheeze and eczema in offspring was analyzed while considering dietary folate intake. We examined 84,361 mothers and 85,114 children in the Japan Environment and Children's Study. The participants were divided into three groups depending on maternal folic acid supplementation ("no use," "occasional use," and "daily use"). Each group was then subdivided into three groups based on total folic acid and dietary folate intake. Outcomes were determined considering the wheeze and eczema status of each child at the age of 2 years. The status was based on the International Study of Asthma and Allergies in Childhood. It was found that 22.1% of the mothers took folic acid supplements daily. In contrast, 56.3% of the mothers did not take these supplements. Maternal intake of folic acid supplements was not associated with wheeze and eczema in the offspring. In contrast, only dietary folate intake was positively associated with wheeze at the age of 2 (adjusted odds ratio, 1.103; 95% confidence interval, 1.003-1.212). However, there is no scientific evidence of a biological mechanism that clarifies this result. Potential confounders such as other nutrition, outdoor/indoor air pollution, and genetic factors may have affected the results. Therefore, further studies on the association between maternal intake of folic acid and allergic symptoms at the age of 3 or above are needed to confirm the results of this study. Trial registration UMIN Clinical Trials Registry (number: UMIN000030786).
Subject(s)
Eczema , Hypersensitivity , Prenatal Exposure Delayed Effects , Child , Dietary Supplements/adverse effects , Eczema/epidemiology , Eczema/etiology , Female , Folic Acid/adverse effects , Humans , Japan/epidemiology , Mothers , Pregnancy , Respiratory Sounds/etiology , Surveys and QuestionnairesABSTRACT
Aims: To summarize the relationship between vitamin D and infant asthma or wheeze.Materials and methods: We used PubMed and Embase to search articles through July 2017 with selection criteria for relevant studies. Random-effect models were used to pool the results of included studies.Results: Ten articles with 14 independent reports of 2073 incident cases of asthma and 1875 cases of wheeze among 23 030 pairs of mother and child were included in our meta-analysis. Compared to those who did not take vitamin D, the mothers who had vitamin D supplementation during pregnancy stage could reduce the risk of asthma or wheeze in infants. The combined odds ratio of infant wheeze was 0.65 (95% CI = 0.54-0.79) and asthma was 0.78 (95% CI = 0.69-0.89). The results almost did not change in the subgroup analyses.Conclusions: It suggests that increasing maternal vitamin D intake during pregnancy might have a protective effect on suffering from wheeze and asthma for children.
Subject(s)
Asthma , Respiratory Sounds , Asthma/epidemiology , Asthma/etiology , Child , Female , Humans , Infant , Observational Studies as Topic , Odds Ratio , Pregnancy , Respiratory Sounds/etiology , Vitamin D , VitaminsABSTRACT
OBJECTIVE: This study describes the burden of prematurity-associated wheezing in black infants with respect to caregiver missed work. STUDY DESIGN: We analyzed data from the D-Wheeze trial (ClinicalTrials.gov identifier NCT01601847). Black infants between 28-0/7 to 36-6/7 weeks' gestational age at birth receiving <28 days of supplemental oxygen were enrolled. The primary outcome was missed work to care for the infant in the first year. RESULTS: 147/277 (53.1%) infants had caregivers who reported time off. In an adjusted model, vitamin D supplementation (OR 0.52 [95% CI 0.30-0.89]; P = 0.018), recurrent wheeze (OR 2.26 [95% CI, 1.15-4.44]; P = 0.018), and other children in the household <5 years old (OR 0.45 [95% CI 0.26-0.78]; P = 0.004) were significantly associated with caregiver missed work. CONCLUSIONS: Black premature infants had a significant burden of caregiver missed work, emphasizing the impact of prematurity-associated wheezing.
Subject(s)
Caregivers , Infant, Premature, Diseases , Child , Child, Preschool , Gestational Age , Humans , Infant , Infant, Newborn , Infant, Premature , Respiratory Sounds/etiologyABSTRACT
This study was conducted to investigate the clinical syndromes of asthma in children based on the detection of key indicators. A total of 50 children with asthma were selected based on the asthma diagnostic methods categorised according to cough, wheezing, sputum and wheezing sound. The levels of D-dimer (DD) and fibrinogen (Fg) in plasma and blood gas analysis were also measured. The diagnostic symptoms were divided into TCM diagnostic statistics and western medicine diagnostic scores. The analysis showed male children to be affected much more than female children, and the age of 2-5 years was more common. Blood tests showed that the plasma levels of DD and Fg in children with acute asthma increased significantly. The onset of asthma in children was closely related to history of allergy and family inheritance. More than half of the children had a history of allergy. Respiratory tract infection caused by cold air was the most important cause of asthma in children. Most children with asthma were febrile with cough (moderate to severe) and sputum. The syndromes in this study included wind-heat syndrome, lung-qi deficiency syndrome and wind-cold syndrome, which could lay a foundation for the prevention, diagnosis and treatment of asthma in children.
Subject(s)
Asthma , Medicine, Chinese Traditional , Asthma/diagnosis , Asthma/epidemiology , Child , Child, Preschool , Female , Humans , Lung , Male , Respiratory Sounds/etiology , SyndromeABSTRACT
BACKGROUND: Information is scarce about the occupational health effects of exposure to alumina dust. This study examines the respiratory effects of inspirable alumina dust exposure in alumina refineries. METHODS: An inception cohort study at three alumina refineries in Western Australia recruited 416 participants (351 males, 65 females) between 1995 and 2000 who were followed up annually until 2008 or until exit from study. At each health interview a respiratory questionnaire and lung function test was undertaken, measuring forced expiratory volume in one second (FEV1 ) and forced vital capacity (FVC). Participants provided job histories which were combined with air monitoring data to calculate cumulative exposure to inspirable alumina dust (mg/m3 -years). Generalized estimating equations with Poisson distribution and mixed effects models were used to examine the effects of alumina exposure. RESULTS: The number of exposed participants was relatively small (n = 82, 19.7%). There was no association between alumina dust exposure and prevalence of cough, wheeze or rhinitis. No associations were found between measures of lung function and tertiles of alumina exposure in the first two follow-ups, or the whole follow-up period, though there was a suggestive dose-response trend across exposed groups for decline in absolute FEV1 (p for trend = .06). For mean annual change in FEV1 and FVC based on the first three follow-ups it was not possible to rule out an effect above a threshold level of exposure. CONCLUSION: There is no evidence of an association between exposure to alumina and the reporting of respiratory symptoms but some evidence for an effect on lung function.
Subject(s)
Air Pollutants, Occupational/toxicity , Aluminum Oxide/toxicity , Inhalation Exposure/adverse effects , Lung Diseases/epidemiology , Occupational Diseases/epidemiology , Occupational Exposure/adverse effects , Adult , Cough/epidemiology , Cough/etiology , Dust , Extraction and Processing Industry , Female , Humans , Longitudinal Studies , Lung Diseases/etiology , Male , Occupational Diseases/etiology , Prevalence , Respiratory Function Tests , Respiratory Sounds/etiology , Rhinitis/epidemiology , Rhinitis/etiology , Skin Tests , Western Australia/epidemiologyABSTRACT
OBJECTIVE: To determine the prevalence of vitamin D deficiency/insufficiency in children 0-18 years of age with recurrent wheezing and/or asthma residing in the microregion of Viçosa, Minas Gerais, Brazil, and treated at a referral center, and to determine its association with major risk factors for wheezing. METHODS: A cross-sectional study was performed using a semi-structured questionnaire, which was administered by trained interviewers to the legal guardians of the study participants. Data were obtained regarding general characteristics of recurrent wheezing; general sociodemographic, environmental, and biologic factors; and atopy-related factors. The magnitude of the statistical association was assessed by calculating ORs and their corresponding 95% CIs by using multiple logistic regression. RESULTS: We included 124 children in the study. The prevalence of vitamin D deficiency/insufficiency in the sample was 57.3%. Vitamin D deficiency/insufficiency was found to be associated with wheezing in the first year of life, personal history of atopic dermatitis, environmental pollution, and vitamin D supplementation until 2 years of age. CONCLUSIONS: The prevalence of vitamin D deficiency/insufficiency was high in our sample. Vitamin D concentrations were directly associated with vitamin D supplementation until 2 years of age and were inversely associated with wheezing events in the first year of life, personal history of atopic dermatitis, and environmental pollution.
Subject(s)
Respiratory Sounds/etiology , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology , Age Distribution , Asthma/etiology , Brazil/epidemiology , Child , Child, Preschool , Cross-Sectional Studies , Dermatitis, Atopic/etiology , Humans , Infant , Logistic Models , Multivariate Analysis , Prevalence , Reference Values , Risk Factors , Sex Distribution , Socioeconomic Factors , Vitamin D/blood , Vitamin D/therapeutic useABSTRACT
BACKGROUND: While familial clustering of asthma is known, few studies have reported on the relative roles of paternal and maternal asthma and the role of maternal asthma control in pregnancy on the risk for asthma in the child. OBJECTIVE: We aimed to investigate the relative roles of paternal asthma, maternal asthma, and maternal asthma control during pregnancy on the risk of asthma or recurrent wheeze in 3-year-old children and how prenatal and cord blood vitamin D status might affect this risk. METHODS: Data from 806 women, their partners (biologic fathers of the infants), and their children participated in the Vitamin D Antenatal Asthma Reduction Trail (VDAART, clinicaltrials.gov identification number NCT00920621) were used for this cohort analysis. The parental report of physician-diagnosed asthma or recurrent wheeze in offspring was the main outcome. Weibull regression models for interval-censored event times were used to estimate the main variables of interests and additional covariates on the outcome. RESULTS: The highest risk was observed among children with both parents being asthmatic relative to non-asthmatic parents (aHR = 2.30, 95% CI: 1.35-3.84), and less so if only the mother was asthmatic (aHR = 1.70, 95% CI: 1.17-2.40). In the subset of children born to asthmatic mothers, the risk for asthma was higher in those who were born to mothers whose asthma was uncontrolled (aHR = 1.60, 95% CI: 1.02-2.54). Children whose mothers had sufficient vitamin D status (25Hydroxyvitamin D ≥ 30 ng/mL) at early and late pregnancy and had cord blood vitamin D sufficiency demonstrated a lower risk of asthma/recurrent wheeze than children who had insufficient cord blood vitamin D status at birth (aHR = 0.47, 95% CI: 0.27-0.83). CONCLUSION AND CLINICAL RELEVANCE: Careful attention to maternal asthma control, monitoring vitamin D status, and correcting insufficiency at early pregnancy and maintaining the sufficiency status throughout pregnancy have potential preventive roles in offspring asthma or recurrent wheeze.
Subject(s)
Asthma/epidemiology , Asthma/etiology , Disease Susceptibility , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects , Respiratory Sounds/etiology , Vitamin D/blood , Adult , Age Factors , Child, Preschool , Dietary Supplements , Female , Humans , Infant , Kaplan-Meier Estimate , Male , Patient Outcome Assessment , Pregnancy , Prognosis , Randomized Controlled Trials as Topic , Vitamin D/administration & dosageABSTRACT
ABSTRACT Objective: To determine the prevalence of vitamin D deficiency/insufficiency in children 0-18 years of age with recurrent wheezing and/or asthma residing in the microregion of Viçosa, Minas Gerais, Brazil, and treated at a referral center, and to determine its association with major risk factors for wheezing. Methods: A cross-sectional study was performed using a semi-structured questionnaire, which was administered by trained interviewers to the legal guardians of the study participants. Data were obtained regarding general characteristics of recurrent wheezing; general sociodemographic, environmental, and biologic factors; and atopy-related factors. The magnitude of the statistical association was assessed by calculating ORs and their corresponding 95% CIs by using multiple logistic regression. Results: We included 124 children in the study. The prevalence of vitamin D deficiency/insufficiency in the sample was 57.3%. Vitamin D deficiency/insufficiency was found to be associated with wheezing in the first year of life, personal history of atopic dermatitis, environmental pollution, and vitamin D supplementation until 2 years of age. Conclusions: The prevalence of vitamin D deficiency/insufficiency was high in our sample. Vitamin D concentrations were directly associated with vitamin D supplementation until 2 years of age and were inversely associated with wheezing events in the first year of life, personal history of atopic dermatitis, and environmental pollution.
RESUMO Objetivo: Determinar a prevalência da deficiência/insuficiência de vitamina D em indivíduos com sibilância recorrente e/ou asma com idade de 0-18 anos e residentes na microrregião de Viçosa (MG) atendidos em um centro de referência e determinar sua associação com os principais fatores de risco para sibilância. Métodos: Estudo transversal utilizando um questionário semiestruturado por entrevistadores treinados, aplicado aos responsáveis pelos participantes do estudo. Foram obtidas informações sobre características gerais da sibilância recorrente, fatores sociodemográficos, ambientais e biológicos gerais e aqueles relacionados à atopia. A magnitude da associação estatística foi avaliada por meio do cálculo da OR e IC95% obtidos por regressão logística múltipla. Resultados: Foram incluídos 124 indivíduos no estudo. A prevalência da deficiência/insuficiência de vitamina D na amostra foi de 57,3%. Observaram-se associações da deficiência/insuficiência de vitamina D com sibilância no primeiro ano de vida, antecedentes pessoais de dermatite atópica, poluição ambiental e suplementação de vitamina D até os 2 anos de idade. Conclusões: A prevalência de deficiência/insuficiência de vitamina D foi alta em nossa amostra. As concentrações de vitamina D foram associadas diretamente com a suplementação de vitamina D até os 2 anos de idade e inversamente com eventos de sibilância no primeiro ano de vida, antecedentes pessoais de dermatite atópica e poluição ambiental.
Subject(s)
Humans , Infant , Child, Preschool , Child , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology , Respiratory Sounds/etiology , Reference Values , Asthma/etiology , Socioeconomic Factors , Vitamin D/blood , Vitamin D/therapeutic use , Brazil/epidemiology , Logistic Models , Prevalence , Cross-Sectional Studies , Multivariate Analysis , Risk Factors , Sex Distribution , Age Distribution , Dermatitis, Atopic/etiologyABSTRACT
Research linking pollen grains in the air with allergy cases (pollinosis) is still incipient in Africa. To close this gap, aerosamplers were placed in Gbagada, Lagos State and harvested monthly from January 2013 to December 2014. Data obtained was correlated with allergy cases (wheezing cough, rhinitis, and allergic conjunctivitis) from Gbagada General Hospital Lagos. Dominant pollen grains recovered were those of Alchornea cordifolia, Amaranthaceae, Casuarina equisetifolia, Cyperaceae, and Poaceae. Pollinosis data revealed that wheezing cough had the highest records in 2013 (1153) and 2014 (1409) while individuals of the age group 15-49 years had the highest number of pollinosis cases for both years. Peak pollen season in 2013 was from October-December; similarly, October, November, and December recorded the highest incidence of wheezing cough (225), rhinitis (21), and allergic conjunctivitis (56) respectively. In 2014, peak pollen season was from October-March while October recorded the highest number of cases of allergic conjunctivitis and rhinitis (81 and 32 respectively) and wheezing cough cases were highest in November (299). Total pollen count had positive significant correlation (p ≤ 0.05) with wheezing cough cases for both years. Individually, each dominant pollen had positive significant correlation (p ≤ 0.05) with wheezing cough cases in 2013 while only Cyperaceae and Poaceae pollen had positive significant correlation (p ≤ 0.05) with wheezing cough in 2014. Continuous collection of aeropollen and pollinosis data from more locations within Nigeria is recommended to provide an appropriate epidemiology of pollinosis cases in the country and ascertain possible responsible pollen grains.
Subject(s)
Cough/etiology , Hypersensitivity/etiology , Plants , Pollen/immunology , Respiratory Sounds/etiology , Rhinitis, Allergic, Seasonal/etiology , Seasons , Adolescent , Adult , Amaranthaceae , Child , Child, Preschool , Cyperaceae , Environmental Monitoring , Euphorbiaceae , Female , Humans , Hypersensitivity/epidemiology , Incidence , Infant , Male , Middle Aged , Nigeria , Poaceae , Rhinitis, Allergic, Seasonal/epidemiology , Young AdultABSTRACT
BACKGROUND: Vitamin D deficiency has been linked to an increased risk of asthma. This study aimed to quantify the effect of early life vitamin D status on asthma and wheeze later in life. METHODS: PubMed, Embase, CINAHL, and CNKI databases, the Cochrane Central Register of Controlled Trials, and Google Scholar were searched up to July 2017. We included randomized controlled trials (RCTs) and cohort studies with vitamin D level in blood (maternal or cord or infant) or intake (maternal intake during pregnancy or infant intake) and asthma and/or wheeze. Two reviewers independently extracted data. Fixed- and random-effects models were used to summarize the risk estimates of comparisons between highest vs. lowest vitamin D categories. RESULTS: Of the 1485 studies identified, three RCTs and 33 cohort studies were included. We did not include the RCTs (1619 participants) in the meta-analysis as the comparators and outcome definitions were heterogenous. Three RCTs reported a non-statistically significant effect of vitamin D supplementation during pregnancy on offspring wheeze/asthma at 3 years of age. Pooled estimates of cohort studies suggest no association between antenatal blood vitamin D levels or vitamin D intake and offspring asthma assessed either > 5 years or ≤ 5 years. The estimate for blood vitamin D remained unchanged when two studies assessing asthma in adulthood were excluded, but a significant inverse association emerged between vitamin D intake and childhood asthma. We found no association between antenatal vitamin D level and wheeze. On the other hand, vitamin D intake during pregnancy may have a protective effect against wheeze. CONCLUSIONS: The pooled estimates from cohort studies show no association between antenatal blood vitamin D level and asthma/wheeze in later life. Whereas, the pooled estimates from cohort studies suggest that antenatal vitamin D intake may have an effect on childhood asthma > 5 years or childhood wheeze. The inconsistent results from studies assessing vitamin D either in blood or intake may be explained by previously reported non-linear association between blood vitamin D3 and childhood asthma. Further trials with enough power and longer follow-up time should be conducted to confirm the results.
Subject(s)
Asthma/blood , Pregnancy Complications/prevention & control , Vitamin D Deficiency/prevention & control , Vitamin D/blood , Vitamin D/pharmacology , Asthma/physiopathology , Child, Preschool , Cohort Studies , Dietary Supplements , Female , Humans , Pregnancy , Respiratory Sounds/etiologyABSTRACT
Objectives Folate plays a vital role in biologic functions yet women often do not meet the recommended dietary intake in pregnancy. It has been suggested that high folic acid intake during pregnancy may increase the risk of respiratory diseases in offspring. However, findings from observational studies in human populations are inconclusive. Methods In this population-based study, we collected self-reported folic acid and prenatal vitamin supplement use during pregnancy 3-6 months postpartum from mothers in Los Angeles whose children were born in 2003. Supplement initiation was based on whichever supplement, either folic acid or prenatal supplements, the women initiated first. In a 2006 follow-up survey, approximately 50% of women were re-contacted to gather information on the child's respiratory health, including symptoms and diagnoses, at approximately 3.5 years of age. Results Overall, timing of folic acid supplement initiation was not associated with wheeze or lower respiratory tract infection, even after accounting for preterm births and censoring at follow-up. However, children born to mothers with a history of atopy (hay fever, eczema or asthma) who initiate folic acid supplements in late pregnancy, compared to first trimester initiators, have 1.67 (95% CI 1.12, 2.49) times the risk of wheeze in the first 3 years of life and 1.88 (95% CI 1.05, 3.34) times the risk of wheeze in the past year. No association was found among children of non-atopic mothers. Conclusions These findings suggest that early folic acid or prenatal supplementation among atopic women may be important to prevent wheeze among offspring.
Subject(s)
Dietary Supplements , Folic Acid/administration & dosage , Population Surveillance/methods , Prenatal Care/methods , Prenatal Exposure Delayed Effects/chemically induced , Respiratory Sounds/etiology , Respiratory Tract Infections/epidemiology , Adult , Asthma/chemically induced , Asthma/epidemiology , Child , Child, Preschool , Female , Health Surveys , Humans , Male , Pregnancy , Pregnancy Trimester, First , Respiratory Hypersensitivity/chemically induced , Respiratory Hypersensitivity/epidemiology , Respiratory Tract Infections/chemically induced , United States/epidemiologyABSTRACT
Asthma is a heterogeneous disease with multiple phenotypes. Epidemiologic studies suggest a close relationship between vitamin E and the occurrence of asthma, wheezing and atopic conditions during childhood. Previous results on its effects have been conflicting. The aim of this meta-analysis was to critically examine the current evidence on the association of vitamin E with childhood asthma and wheezing. We searched electronic databases for observational studies in English-language journals published from 2000 to 2016. The initial search found 420 titles; nineteen studies were eligible according to the abstracts and details, which included reporting asthma or wheeze as an outcome. None of the articles included in this meta-analysis reported side effects of vitamin E supplementation during pregnancy. This meta-analysis found that vitamin E supplementation during pregnancy influenced the risk of asthma. To better understand the effectiveness and safety of vitamin E in children with asthma, large-scale, well-designed and randomized controlled trials are needed.
Subject(s)
Asthma , Respiratory Sounds/drug effects , Vitamin E/pharmacology , Asthma/physiopathology , Asthma/prevention & control , Child , Humans , Observational Studies as Topic , Outcome Assessment, Health Care , Respiratory Sounds/etiology , Vitamins/pharmacologyABSTRACT
BACKGROUND: Prenatal folic acid supplementation is recommended to prevent birth defects. Some foods are fortified in the USA to ensure sufficient intake among reproductive-aged women. However, high prenatal folate exposure may be a risk factor for childhood atopic diseases. We investigated associations between prenatal folate and early childhood wheeze and atopic dermatitis in a US cohort. METHODS: We studied 858 mother-child dyads, enrolled prenatally. Folate was measured in 2nd and 3rd trimester maternal plasma. Parents reported current wheeze (previous 12 months) and healthcare provider diagnosis of atopic dermatitis at 3 years. We examined associations using logistic regression, modeling folate continuously and dichotomously (< or ≥20 ng/mL), a level often considered supraphysiologic. RESULTS: Over half of women were African American and on Medicaid. Median (interquartile range) folate levels were 22.6 (15.9-30.0) and 23.1 (16.1-30.0) ng/mL for 2nd and 3rd trimesters, respectively. Current wheeze and atopic dermatitis were reported for 20.4% and 26.8% of children, respectively. Second trimester folate as a continuous exposure was not significantly associated with outcomes. Decreased odds of current wheeze were observed in children born to mothers who had 2nd trimester folate ≥20 ng/mL (adjusted odds ratios = 0.67, 95% confidence interval = 0.46, 0.97) compared to children with maternal levels <20 ng/mL. Third trimester folate was not associated with outcomes. CONCLUSIONS: High plasma folate in mid-pregnancy was associated with decreased odds of current wheeze at age 3. Our findings do not support harmful effects of high prenatal folate levels on childhood atopic diseases in this setting.
Subject(s)
Dermatitis, Atopic/etiology , Folic Acid/adverse effects , Respiratory Sounds/etiology , Adolescent , Adult , Child, Preschool , Dermatitis, Atopic/epidemiology , Female , Folic Acid/blood , Humans , Male , Pregnancy , Prenatal Exposure Delayed Effects/epidemiology , Prospective Studies , Risk Factors , United States , Young AdultABSTRACT
BACKGROUND: We reported a tubeless tracheal resection and reconstruction for the management of benign posttracheostomy tracheal stenosis. METHODS: A 34-year-old man with stridor, severe respiratory distress, and recurrent pneumonia was referred to our attention for treatment of benign posttracheostomy tracheal stenosis. As he refused general anesthesia, the procedure was performed while he was under local anesthesia and spontaneous ventilation. RESULTS: Sedation was started with infusion of dexmedetomidine 0.7 mg/kg/min and of remifentanil 0.5 mg/kg/h; also, 40%-50% oxygen was delivered using a laryngeal mask at a rate of 3.5 mL/min. An additional dose of 2% lidocaine was injected into the surgical site during the operation to achieve an adequate level of anesthesia. A standard resection and reconstruction of trachea was carried out and no recurrence was found in the follow-up of 41 months. CONCLUSION: Tubeless tracheal surgery seems to be a feasible and safe procedure. Larger prospective series should validate our results.
Subject(s)
Anesthesia, Local/methods , Trachea/surgery , Tracheal Stenosis/surgery , Tracheostomy/adverse effects , Adult , Anastomosis, Surgical , Bronchoscopy/methods , Follow-Up Studies , Humans , Male , Patient Safety , Plastic Surgery Procedures/methods , Respiratory Sounds/diagnosis , Respiratory Sounds/etiology , Risk Assessment , Tomography, X-Ray Computed/methods , Tracheal Stenosis/etiology , Tracheal Stenosis/pathology , Tracheostomy/methods , Tracheotomy/methods , Treatment OutcomeABSTRACT
BACKGROUND: We investigated the net changes in prevalence of symptoms of asthma and rhinitis over 10 years in a cohort of young by baseline sensitization status. METHODS: One thousand one hundred ninety three Chilean adults subjects aged 22-28 living in a semi-rural area of central Chile answered a lifestyle and the European Community Respiratory Health Survey (ECRHS) questionnaires. Bronchial hyper-responsiveness (BHR) and skin prick test (SPT) to eight allergens were measured at baseline in 2001. Ten years later, 772 participants completed the questionnaires again. Estimates of adjusted net changes in prevalence of symptoms by sensitization status at baseline and association between sensitization status at baseline and respiratory symptoms ten years later were assessed. RESULTS: A quarter of the participants were sensitized to at least one allergen in 2001. Prevalence of wheeze had a net change per year of -0.37 % (95 % Confidence Interval -0.71 to 0.02 %; p = 0.067). Self-reported nasal allergies in the last 12 months increased by 0.83 % per year (95 % CI 0.49 to 1.17 %; p < 0.001). Those sensitized to either cat fur (OR 1.76; CI 1.01 to 3.05), cockroach, (OR 2.09; 1.13 to 3.86) blend of grass and pollens (1.78; 95 % CI 1.08 to 2.92), or weeds (OR 1.77; 95 % CI 1.01 to 3.12) in 2001 were more likely to have wheeze in the last 12 months 10 years later. CONCLUSION: Symptoms of asthma remained stable or slightly changed over 10 years in adults, whilst rhinitis and nasal allergies greatly increased. Being sensitized to at least one allergen is a risk factor for persistent symptoms of asthma and rhinitis, but not for determining net changes of symptoms over time. The underlying causes for the contrasting trends between asthma and nasal allergy are unknown.
Subject(s)
Asthma/epidemiology , Respiratory Sounds/etiology , Rhinitis, Allergic, Seasonal/epidemiology , Adult , Allergens/immunology , Animals , Cats , Chile/epidemiology , Cockroaches/immunology , Dogs , Female , Humans , Immunoglobulin E/blood , Logistic Models , Male , Pollen/immunology , Prospective Studies , Skin Tests , Young AdultABSTRACT
OBJECTIVE: To provide recommendations for the comprehensive management of young infants who present with signs or symptoms concerning for laryngomalacia. METHODS: Expert opinion by the members of the International Pediatric Otolaryngology Group (IPOG). RESULTS: Consensus recommendations include initial care and triage recommendations for health care providers who commonly evaluate young infants with noisy breathing. The consensus statement also provides comprehensive care recommendations for otolaryngologists who manage young infants with laryngomalacia including: evaluation and treatment considerations for commonly debated issues in laryngomalacia, initial work-up of infants presenting with inspiratory stridor, treatment recommendations based on disease severity, management of the infant with feeding difficulties, post-surgical treatment management recommendations, and suggestions for acid suppression therapy. CONCLUSION: Laryngomalacia care consensus recommendations are aimed at improving patient-centered care in infants with laryngomalacia.
Subject(s)
Algorithms , Consensus , Disease Management , Laryngomalacia/surgery , Female , Humans , Infant , Infant, Newborn , Laryngomalacia/complications , Laryngomalacia/diagnosis , Male , Patient-Centered Care , Practice Guidelines as Topic , Respiratory Sounds/etiology , TriageABSTRACT
Airway mucormycosis is a deadly opportunistic infection that affects immunocompromised persons, particularly diabetics and those undergoing chemotherapy. Although it is typically a pulmonary or sinonasal infection, mucormycosis can affect the larynx and trachea, with devastating results. We report the case of a 46-year-old man with human immunodeficiency virus infection, hepatitis C infection, neurosyphilis, and recently diagnosed Burkitt lymphoma who presented with dysphonia and stridor after receiving one dose of intrathecal chemotherapy. Flexible laryngoscopy detected the presence of fibrinous material that was obstructing nearly the entire glottis. Surgical debridement revealed a firm mucosal attachment; there was little bleeding when it was removed. After debridement, the patient's dyspnea improved only to recur 2 days later. After an awake tracheotomy, laryngoscopy and bronchoscopy identified necrosis extending from the supraglottic area to the carina tracheae. Biopsies demonstrated hyphal architecture consistent with mucormycosis. Despite continued debridements, the fibrinous material reaccumulated. The patient was placed in hospice care; his airway remained patent, but he died from other causes several weeks after presentation. The management of airway mucormycosis is challenging and complex. Fungal airway infections should be considered in the differential diagnosis of an immunosuppressed patient who presents with dyspnea, dysphonia, and vocal fold immobility. Timely diagnosis and management are critical for a successful outcome, although the prognosis is poor if the infection is widespread, even with the best of efforts.